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Assessment on Experimental Bacterial Biofilms and in Clinical Practice
of the Efficacy of Sampling Solutions for Microbiological Testing
of Endoscopes
C. Aumeran,a E. Thibert,a F. A. Chapelle,a C. Hennequin,c O. Lesens,b and O. Traoréa
Service d’Hygiène Hospitalièrea and Maladies Infectieuses,b Pôle REUNNHIR, CHU Clermont-Ferrand, Clermont-Ferrand, France, and Laboratoire de Bactériologie, UFR
Pharmacie, Clermont-Ferrand, Francec
Opinions differ on the value of microbiological testing of endoscopes, which varies according to the technique used. We com-
pared the efficacy on bacterial biofilms of sampling solutions used for the surveillance of the contamination of endoscope chan-
nels. To compare efficacy, we used an experimental model of a 48-h Pseudomonas biofilm grown on endoscope internal tubing.
Sampling of this experimental biofilm was performed with a Tween 80-lecithin-based solution, saline, and sterile water. We also
performed a randomized prospective study during routine clinical practice in our hospital sampling randomly with two differ-
ent solutions the endoscopes after reprocessing. Biofilm recovery expressed as a logarithmic ratio of bacteria recovered on bacte-
ria initially present in biofilm was significantly more effective with the Tween 80-lecithin-based solution than with saline solu-
tion (P  0.002) and sterile water (P  0.002). There was no significant difference between saline and sterile water. In the
randomized clinical study, the rates of endoscopes that were contaminated with the Tween 80-lecithin-based sampling solution
and the saline were 8/25 and 1/25, respectively (P  0.02), and the mean numbers of bacteria recovered were 281 and 19 CFU/100
ml (P  0.001), respectively. In conclusion, the efficiency and therefore the value of the monitoring of endoscope reprocessing by
microbiological cultures is dependent on the sampling solutions used. A sampling solution with a tensioactive action is more
efficient than saline in detecting biofilm contamination of endoscopes.
Endoscopes have a high bioburden of microorganisms after use(8) and are difficult to clean and disinfect because of their
complicated design, long narrow lumens and because of the ma-
terials used in their manufacture (2). Endoscope reprocessing is a
multistep procedure involving numerous factors that can inter-
fere with its efficacy. To ensure the quality of the reprocessing,
strict compliance with the disinfection procedure is mandatory,
and a regular audit of all of the steps in reprocessing is crucial.
Despite the publication of reprocessing guidelines, breaches in
reprocessing practices continue to be reported, and failure to fol-
low cleaning or disinfection guidelines can result in outbreaks
involving a large number of patients (24). The microbiological
safety of endoscopes can also be affected by occult endoscope
damage and contaminated automated endoscope reprocessors,
and thus quality control for endoscope reprocessing is extremely
important. However, there is continuing debate about the role
and value of surveillance cultures in the quality assurance pro-
gram of endoscope reprocessing (24). Many authors recommend
endoscope surveillance cultures, and several recent reports of
endoscopy-related outbreaks have stressed the importance that
these cultures have played or could have played in the prevention
of these adverse events (4, 15, 19, 20). Even the recent guidelines of
the American Society for Gastrointestinal Endoscopy (ASGE),
which do not recommend routine microbiological testing of en-
doscopes, state that this question warrants further studies (3). The
value of surveillance cultures is likely dependent on how often
endoscopes are sampled and by what technique. Samplings of in-
ternal channels of endoscopes usually rely on flushing the chan-
nels, generally with saline or sterile water, and sometimes in com-
bination with brushing of the internal channels. Very few studies
have attempted to evaluate the efficacy of the sampling methods of
endoscope channels (17). In addition, and despite increasing evi-
dence of the implication of biofilms in endoscope contamination,
no published data are available on how efficient these methods are
on bacterial biofilms (6, 22, 24).
In the present study, we compared the efficacy of several sam-
pling solutions used for the microbial surveillance of the contam-
ination of endoscope internal channels on bacterial biofilms. To
compare efficacy, we used an experimental model of biofilm
grown on endoscope internal tubing and performed an in-use
evaluation sampling the endoscopes during routine clinical prac-
tice with two different sampling solutions.
MATERIALS AND METHODS
Biofilm formation. A Pseudomonas aeruginosa (CIP 103.467; Collection
Institut Pasteur, Paris, France) biofilm was produced over 48 h inside a
flexible Teflon tube (Tygon, R3603; Cole-Parmer, Vernon Hills, IL) (Fig.
1). Our laboratory model of biofilm production was based on an experi-
mental model described elsewhere (23). The sterile Teflon tube was con-
nected to a sterile polyvinylchloride tube (Nalgene, Illkirch, France) to
form a loop that was supplied with tryptone soy broth culture medium
(TSB; CM129; Oxoid, Cambridge, England). The system was activated by
two pumps (Watson Marlow 205S; La Queue, Lez Yvelines, France), one
providing a continuous flow of TSB medium in the system and the second
providing a homogenous diffusion of the TSB and of the P. aeruginosa
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suspension in the loop (Fig. 1). The circuit was inoculated with 20 ml  1
ml of a suspension containing ca. 108 P. aeruginosa organisms per ml.
Recovery and numeration of viable bacteria from the biofilm. We
used a mechanical technique based on scraping, vortexing, and ultrasoni-
cation to recover the biofilm in a saline solution as previously described
(23). The solution was then diluted and plated on Trypticase soy agar
(TSA).
Endoscope sampling solutions. We tested a commercially available
Letheen broth (VWR Prolabo, Fontenay Sous Bois, France) composed of
Tween 80 (0.5% [vol/vol]), meat peptone (1% [wt/vol]), meat extract (0.5
[wt/vol]), sodium chloride (0.5% [wt/vol]) and lecithin (0.07% [wt/vol]),
0.9% sterile saline solution, and sterile water.
Portions (2 ml) of the sampling solutions tested were instilled with a
syringe for 30 s in 3-cm portions of the Teflon tube, recovered, and diluted
up to 106. Portions (500 l) of 104 to 106 dilutions were plated in
duplicate on TSA plates that were incubated at 37°C for 24 h. The bacterial
counts are expressed as CFU per cm2 or log10 CFU/cm
2.
Sampling of endoscopes after reprocessing in routine clinical prac-
tice. The 61 endoscopes included in the prospective randomized clinical
study came from the teaching hospital of Clermont-Ferrand, France. They
were divided into six types: gastroscope, duodenoscope, colonoscope,
echoendoscope, bronchoscope, and cystoscope. For each type, half of the
endoscopes were randomized to a sterile saline solution group or to the
Letheen broth group.
The sampling method is used routinely in our hospital and follows
French guidelines (10). Sampling is performed aseptically by two people
after alcohol-based hand-rubbing. The ends of the channels are disin-
fected by 60°C alcohol with a sterile gauze. A total volume of 100 ml of the
tested sampling solution is injected inside the operating, suction, and
air/water channels. The pooled sample was then collected from the oper-
ating channel. The identity of the endoscope, the duration of storage
before sampling, the date of the last disinfection and/or the last cleaning,
and the type of disinfection/cleaning (manual or automated) are re-
corded.
Microbiological identification. The sample was filtered through a
0.45-m-pore-size membrane (EZ-PAK; Millipore, Molsheim, France)
and then rinsed. The membrane was placed on Trypticase soy agar plates
and incubated for 2 days at 30°C and then for 3 days at room temperature.
The viable cell counts were made at 48 h and 5 days and were expressed as
CFU per 100 ml.
The microorganisms were identified by standard procedures. Micro-
bial identification was made by Gram staining for bacteria and scotch test
for fungi.
Gram-positive cocci were identified by coagulase test (Becton Dickin-
son, Le Pont-De-Claix, France) and Chapman plates (Oxoid, Dardilly,
France). Gram-negative bacilli were identified by oxidase testing (Bio-
Rad, Marnes-la-Coquette, France) and the use of API 20 E and API 20 NE
strips (bioMérieux, Lyon, France).
In accordance with our national guidelines (10), a sample was classi-
fied as “unacceptable” if more than 5 CFU per 100 ml and/or the presence
of pathogens (enterobacteriaceae, Pseudomonas aeruginosa, Staphylococ-
cus aureus, Aspergillus spp., and yeast) were detected.
Statistical analyses. (i) Experimental study. The quantity of biofilm
initially present in the Teflon tube was determined in each trial as the
mean bacterial counts (log10 CFU/cm
2) recovered from three tube por-
tions taken as controls. The remaining tube portions (n  7) were sam-
pled by the solution tested: a logarithmic ratio for each tube portion was
calculated with the bacterial count (log10 CFU/cm
2) recovered by the
tested solution in each tube portion as the numerator and the mean bac-
terial count (log10 CFU/cm
2) recovered from the three tube control por-
tions as the denominator. Finally, the mean logarithmic ratios were cal-
culated for the three sampling solutions tested and compared by the
Mann-Whitney test. We also determined the percentage of biofilm recov-
ery for each sampling solution using the mean bacterial count (CFU/cm2)
obtained on the seven portions with the test solution as the numerator and
the mean bacterial count (CFU/cm2) recovered from the three tube con-
trol portions as the denominator.
(ii) Prospective clinical study. Wilcoxon test was used to compare the
overall count of microorganisms (CFU/100 ml) recovered by the saline
solution and the commercially available Letheen broth. The Fisher exact
test was used to compare the proportion of unacceptable samples ob-
tained with each sampling solution used.
P values of 0.05 were considered to indicate statistical significance.
Analyses were performed using SAS software (SAS Institute, Inc.).
RESULTS
Recovery of the 48 h P. aeruginosa biofilm according to solu-
tions used. We first assessed the homogeneity of the biofilm pro-
duced in the Teflon tubes analyzing the bacterial recovery from
five to seven 3-cm samples of the Teflon tube that were cut from
the straight portion and curved portions and at the air-water in-
terface of the Teflon tube loop. The reproducibility of the biofilm
formation in Teflon tubes in three different trials was also as-
sessed. The recovery of viable bacteria from the biofilms produced
in the three different trials were 7.98  0.21, 7.82  0.10, and
8.27  0.19, respectively. These results with low standard devia-
tions show that biofilm formation was quantitatively uniform
throughout the length of the Teflon tube and that it was reproduc-
ible between each trial.
We then compared the bacterial recovery rates after the use of
three test solutions (Letheen broth, 0.9% saline solution, and ster-
ile water) in three independent 48-h Pseudomonas aeruginosa bio-
film trials.
For each trial, the sampling solution was tested on seven por-
tions of 3-cm Teflon tube. Three portions, collected at the ends
and center of the Teflon tube, were used as controls. The viable
cells in the controls were counted using the mechanical recovery
technique. Biofilm formation in the controls was consistent with
the results obtained during the development phase, as shown by
low standard deviations (from 0.06 to 0.28 log10 CFU/cm
2). The
percentage of biofilm recovery was higher after instillation of the
Letheen broth than with the other test solutions: 30.1% versus
2.2% for saline solution and 7.1% for sterile water. These results
were confirmed by comparing, between the three tested solutions,
the mean logarithmic ratios of bacterial counts obtained in each
tube portion (Table 1). The ratios were significantly different be-
tween Letheen broth and sterile water (0.93 versus 0.84; P 
FIG 1 Model of biofilm formation in Teflon tube.
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0.002) and between Letheen broth and saline solution (0.93 versus
0.81; P  0.002). There was no significant difference between sa-
line solution and sterile water (0.81 versus 0.84; P  0.12).
Randomized prospective study of endoscopes. We randomly
sampled 50 (82%) of the 61 endoscopes from our hospital (Table
2). Most were digestive (n  24) and bronchial (n  22). Their
disinfection procedure was performed for most cases in an auto-
mated endoscope disinfector (41/50). The endoscopes came from
different wards: gastroenterology (n  20), pediatrics (n  9),
pneumology (n  8), intensive care units (n  8), urology (n  4),
and thoracic surgery (n  1).
Most endoscopes (47/50) were sampled after 12 h of storage. A
total of 38 microorganisms were found on 33 endoscopes.
According to French guidelines, 34 of these microorganisms can
be considered environmental contaminants (10) (coagulase-
negative staphylococci [n  15], Bacillus spp. [n  8], mold [n 
6], non-Enterobacteriaceae Gram-negative bacilli [n  2], Micro-
coccus spp. [n  2], Corynebacterium sp. [n  1]) and 4 can be
considered potential pathogens (P. aeruginosa in a gastroscope
[n  1], Enterobacter cloacae in a duodenoscope [n  1], and
Aspergillus versicolor in bronchoscopes [n  2]). Most microor-
ganisms (29/38), including all those considered pathogens, were
found when the samplings were performed with Letheen broth.
The count of microorganisms by endoscope was usually low,
and only 9 endoscopes of 50 (18%) were found to have an unac-
ceptable result, with more than 5 CFU per 100 ml and/or the
presence of pathogens. Eight of nine of the unacceptable samples
were found with Letheen broth, which was significantly more ef-
ficient than saline for identifying unacceptable contaminations
(8/25 versus 1/25; P  0.02). The overall CFU count obtained with
the Letheen broth in 25 endoscopes was significantly higher than
that obtained with the saline solution in the 25 other endoscopes
(281 versus 19 CFU; P  0.001).
DISCUSSION
In this study, both experimental evaluation on bacterial biofilms
and in-use clinical results showed that, for the microbiological
testing of internal channels of endoscopes, the use of a tensioactive
sampling fluid was significantly more efficient than sterile water or
saline.
The use of routine environmental microbiological testing of
endoscopes for quality assurance of the cleaning and disinfection
process of the endoscope has not been established and is a matter
of wide debate. A consensus guideline from the European Society
of Gastrointestinal Endoscopy (ESGE) and the European Society
of Gastroenterology and Endoscopy Nurses and Associates
(ESGENA) addresses the need for microbiological surveillance in
endoscopy (5). Recommendations from several countries
TABLE 1 Recovery of P. aeruginosa biofilm with each test solutiona
Tube portion sampled (n  7)
Bacteria recovered from each tube portion (log10 CFU/cm
2)b
Letheen broth Saline solution (0.9%) Sterile water
Bacteria recovered Ratio Bacteria recovered Ratio Bacteria recovered Ratio
Tube portion
1 7.50 0.91 7.11 0.82 6.48 0.85
2 7.79 0.95 7.09 0.81 6.88 0.90
3 7.67 0.93 6.77 0.77 6.56 0.86
4 7.50 0.91 7.11 0.82 6.59 0.86
5 7.53 0.92 7.12 0.82 6.01 0.79
6 7.83 0.95 7.12 0.82 6.02 0.79
7 7.80 0.95 7.31 0.84 6.50 0.85
Mean  SD 7.66  0,15 0.93  0.02 7.09  0.16 0.81  0.02 6.43  0.32 0.84  0.04
a The mean logarithmic counts in control samples (n  3) for biofilm  the standard deviation (log10 CFU/cm
2) for Letheen broth, saline solution, and sterile water were 8.20 
0.06, 8.71  0.28, and 7.64  0.21, respectively. The percentages of biofilm recovery (CFU/cm2) in these control samples for Letheen broth, saline solution, and sterile water were
30.1 (4.8  107/1.6  108), 2.2 (1.3  107/5.8 108), and 7.1 (3.3  106/4.7  107), respectively. The percent biofilm recovery for each sampling solution was calculated using the
mean bacterial count (CFU/cm2) obtained for the seven portions with the test solution as the numerator and the mean bacterial count (CFU/cm2) recovered from the three tube
control portions as the denominator.
b The logarithmic ratio for each tube portion was calculated as the bacterial count (log10 CFU/cm
2) recovered by the tested solution in each tube portion as the numerator and the
mean bacterial count (log10 CFU/cm
2) recovered from the three tube control portions as the denominator.
TABLE 2 Results of prospective endoscope sampling using Letheen
broth or 0.9% saline solution during routine clinical practice
Test solution and
endoscope typea Determination
Storage
duration (h)
Letheen broth
Bronchoscope (n  11) 7 acceptable 36–480
4 unacceptable 12–60
Coloscope (n  5) 5 acceptable 7–48
Gastroscope (n  3) 1 acceptable 12
2 unacceptable 12
Duodenoscope (n  3) 2 acceptable 12
1 unacceptable 12
Echoendoscope (n  1) 1 unacceptable 12
Cystoscope (n  2) 2 acceptable 12–72
Saline solution (0.9%)
Bronchoscopes (n  11) 11 acceptable 48–720
Coloscope (n  3) 3 acceptable 12
Gastroscope (n  6) 6 acceptable 7–48
Duodenoscope (n  2) 1 acceptable 12
1 unacceptable 12
Echoendoscope (n  1) 1 acceptable 2
Cystoscope (n  2) 2 acceptable 12–72
a n  number of samples.
Aumeran et al.
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throughout the world advise microbiological testing of gastroin-
testinal and respiratory endoscopes as a quality control (12, 14,
16). Conversely, microbiological surveillance testing of endo-
scopes after reprocessing, during storage, or before use is not stip-
ulated in current U.S. guidelines (3, 18, 21). However, the recent
guideline of the American Society for Gastrointestinal Endoscopy
(ASGE) stated that this question warrants further studies (3).
There are few documented reports on how to perform the rou-
tine microbiological sampling of endoscopes and no recognized
method for verifying the effectiveness of cleaning and disinfecting
in clinical practice. However, selecting appropriate sampling and
assay methods is essential for the results to be meaningful. The
samplings of internal channels of endoscopes usually consist in
flushing the channels with a fluid, usually saline or sterile water.
Some guidelines favor the use of a neutralizing and more tensio-
active solution based on polysorbate and lecithin (10). Recently,
an antero-retrograde flushing technique with sterile water was
developed to improve the effectiveness of sampling (6). In our
in-use clinical study no retrograde flushing was performed, and
therefore we were unable to compare the efficacy of retrograde
versus anterograde flushing with our tensioactive solution. Most
of the techniques proposed in current guidelines are empirical
and, to our knowledge, very few published studies include a com-
parative and comprehensive evaluation of the sampling tech-
niques (17). Furthermore, no published studies have assessed the
efficacy of the techniques on bacterial biofilms. Biofilm develops
in all wet environments (11). It is now well established that if the
routine cleaning procedure is not rigorous, particularly if an ac-
curate drying procedure is not applied, the microbial contamina-
tion of the endoscopes will be due to bacteria embedded in biofilm
rather than to planktonic (in suspension) bacteria (22, 24). Bac-
teria attached in biofilm are more difficult to kill by disinfectant
than are unattached planktonic bacteria (11); such attached bac-
teria also have very different physiological features (11), and the
removal of biofilm from endoscope channels is much more diffi-
cult than that of planktonic bacteria (1). It is therefore essential to
assess the endoscope microbial sampling technique on biofilms
because their presence requires highly sensitive methods of sam-
pling.
Results from our laboratory contamination model showed that
when the Letheen solution was used for sampling, it achieved a
much higher recovery rate than saline or sterile water of biofilm
contaminating endoscopes. These findings were strengthened by
the results obtained from the random sampling of 50 endoscopes
during daily clinical activity in our hospital. There were many
positive cultures that yielded low counts of bacterial species such
as coagulase-negative staphylococci or Bacillus. The clinical im-
portance of these cultures may be low since it is likely that they do
not represent a significant problem with the disinfection or clean-
ing process. However, sampling with Letheen solution yielded sig-
nificantly more positive results than with saline, whatever the pa-
rameters: the total count of microorganisms recovered, the rate of
overall positive samples, and the rate of samples with pathogens.
Routine microbiological surveillance usually focuses on vegetative
bacteria, fungi, and more rarely mycobacteria and usually ex-
cludes fastidious bacteria, anaerobes, and viruses whose detection
is complex and prohibitively expensive for routine surveillance
purposes (6, 10, 14). Improving the sensitivity of detection of
pathogens such as enteric organisms or Pseudomonas spp. may
have a real direct impact on patient safety. We recently reported an
outbreak due to multiresistant Klebsiella pneumoniae contaminat-
ing duodenoscopes during which routine surveillance cultures of
duodenoscopes performed over several months by saline flushing
failed to detect any contamination. Only when we modified the
sampling procedure of the inner channels, replacing flushing with
saline solution by a Tween 80-lecithin-based solution plus brush-
ing, were we able to isolate the outbreak strains from a contami-
nated endoscope (4).
Previous studies have shown that, in experimentally contami-
nated endoscopes, a single flushing of internal channels with sa-
line solution removes only a very small number of bacteria (9, 13).
The main reason for the greater efficacy of Letheen broth is the
tensioactive action against biofilm of polysorbate (Tween 80),
which is frequently used for its detergent activity (25). In addition,
the Letheen solution could also neutralize the antimicrobial activ-
ity of residual traces of disinfectant present in endoscopes in rou-
tine clinical practice (7).
In conclusion, our experimental data demonstrate that testing
of endoscopes to detect biofilm contamination is much more ef-
ficient with a tensioactive agent than with saline or water. The
microbiological surveillance results obtained during routine clin-
ical practice confirmed the greater efficacy of the tensioactive
agent. If microbiological testing is implemented as a quality con-
trol measure of endoscope reprocessing, the biofilm nature of bac-
teria should be taken into account to assess safety.
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